What progress with artificial livers?

Lancet

Volumn 358, Issue 9290, 2001, Pages 1286-1287

  Hayes, Peter C ^a   Lee, Alistair ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANION EXCHANGE RESIN; CHARCOAL; TOXIN;

ARTIFICIAL LIVER; CELL CULTURE; CELL FUNCTION; CELL SURVIVAL; DEVICE; DIALYSATE; GASTROINTESTINAL HEMORRHAGE; HEMODIALYSIS; HEMODYNAMICS; HEMOPERFUSION; HUMAN; INFECTION; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; MEMBRANE; MORTALITY; NOTE; PLASMAPHERESIS; PRIORITY JOURNAL; SAFETY; TREATMENT OUTCOME;

EID: 0035922625     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)06454-6     Document Type: Note

References (13)

1. Charcoal haemoperfusion in the treatment of fulminant hepatic failure
2. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
3. Haemodynamic changes after high-volume plasmapheresis in patients with chronic and acute liver failure
4. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure
5. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomised, controlled clinical trial
6. Early indicators of prognosis in fulminant failure
7. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure
8. A bioartificial liver to treat severe acute liver failure
9. Extracorporeal application of a gel-entrapment, bioartificial liver: Demonstration of drug metabolism and other biochemical functions
10. Novel bioartificial liver support system: Preclinical evaluation
11. Bioreactor for a larger scale hepatocyte in vitro perfusion
12. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems
13. Prevention of acute liver failure in rats with reversibly immortalised human hepatocytes